AMY PEREZ: Open Payments
NPI 1376268987 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 50 payments from 12 companies in 2025. Trend: 2023 $101 · 2024 $197 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $355 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $183 |
| ABBVIE INC. | 17 | $170 |
| Ardelyx, Inc. | 5 | $106 |
| Gilead Sciences, Inc. | 3 | $55 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| GENZYME CORPORATION | 2 | $44 |
| Janssen Biotech, Inc. | 1 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
Products named: REZDIFFRA, ENTYVIO, LINZESS, IBSRELA, ZENPEP, DUPIXENT, TREMFYA, Wegovy.
Industry payments across TX — which companies pay providers there.
